Introduction As part of a clinical proteomics programme focused on diabetes and its
complications, it was our goal to investigate the proteome of plasma in order to find …

Background As part of a clinical proteomics program focused on diabetes and its
complications we are looking for new and better protein biomarkers for diabetic …

Background Diabetic nephropathy is the most frequent cause of end-stage renal disease
worldwide. Identification of biomarkers for diabetic nephropathy for early diagnosis may be …

Diabetic nephropathy (DN) is a long‐term complication of diabetes mellitus that leads to end‐
stage renal disease. Microalbuminuria is used for the early detection of diabetic renal …

Diabetes is a chronic metabolic disease which can lead to serious health problems
particularly in and to the development of cardiovascular and renal complications. The aim of …

Aim: An advanced proteomics platform for protein biomarker discovery in diabetic chronic
kidney disease (DKD) was developed, validated and implemented. Materials & methods …

Recent advances in quantitative proteomics have offered opportunities to discover plasma
proteins as biomarkers for tracking the progression and for understanding the molecular …

Diabetic nephropathy (DN) is a serious kidney complication of diabetes, and constitutes the
leading cause of end‐stage renal disease. The earliest clinical evidence of DN is …

Diabetic nephropathy (DN) is a renal disease which develops as a consequence of diabetes
mellitus. Microalbuminuria is the earliest clinical sign of DN. There are no specific diagnostic …

Diabetic kidney disease (DKD) is one the major complications of diabetes and has become
the most common cause of chronic kidney disease worldwide [1, 2]. The pathogenesis of …